Bigfoot Biomedical lands $45M as it readies first diabetes product
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
From California to Boston to NYC, four more life science startups have been accepted into the Thiel Foundation's Breakout Labs, a philanthropic incubator for seed-stage companies.